Effects of sildenafil on nanostructural and nanomechanical changes in mitochondria in an ischaemia-reperfusion rat model

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 10, 2014, Pages 763-768

  Lee, Kyung Hye ^a   Kwon, Sung Jin ^a   Woo, Jong Shin ^a   Lee, Gi Ja ^b   Lee, So Ra ^a   Jang, Hyun Hee ^a   Kim, Hyun Soo ^a   Kim, Jung Wook ^a   Park, Hun Kuk ^b   Cho, Kyu Seok ^a   Kim, Weon ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Atomic force microscopy; Ischaemia reperfusion injury; Mitochondria; Myocardial preconditioning; Sildenafil

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; SILDENAFIL; PIPERAZINE DERIVATIVE; POTASSIUM CHANNEL; PURINE DERIVATIVE; SULFONAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL STRUCTURE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MALE; MITOCHONDRION; MITOCHONDRION SWELLING; MOUSE; NONHUMAN; REPERFUSION INJURY; ANIMAL; DRUG EFFECTS; HEART MITOCHONDRION; HEART MUSCLE; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RAT; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; MITOCHONDRIA, HEART; MITOCHONDRIAL SWELLING; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PIPERAZINES; POTASSIUM CHANNELS; PURINES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SULFONAMIDES;

EID: 84911147083     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12290     Document Type: Article

References (32)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N. Engl. J. Med. 2007; 357: 1121-35.
2. Eltzschig HK, Eckle T. Ischemia and reperfusion: From mechanism to translation. Nat. Med. 2011; 17: 1391-401.
3. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: An overview of a decade of research. J. Mol. Cell. Cardiol. 2001; 33: 1897-918.
4. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc. Res. 2006; 70: 240-53.
5. Ghiadoni L, Versari D, Taddei S. Phosphodiesterase 5 inhibition in essential hypertension. Curr. Hypertens. Rep. 2008; 10: 52-7.
6. Kukreja RC, Ockaili R, Salloum F et al. Cardioprotection with phosphodiesterase-5 inhibition: A novel preconditioning strategy. J. Mol. Cell. Cardiol. 2004; 36: 165-73.
7. Reffelmann T, Kloner RA. Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation 2003; 108: 239-44.
8. Salloum FN, Abbate A, Das A et al. Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am. J. Physiol. Heart Circ. Physiol. 2008; 294: H1398-406.
9. Bocchi EA, Guimaraes G, Mocelin A, Bacal F, Bellotti G, Ramires JF. Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: A double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation 2002; 106: 1097-103.
10. Gori T, Sicuro S, Dragoni S, Donati G, Forconi S, Parker JD. Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: A human in vivo study. Circulation 2005; 111: 742-6.
11. Laude K, Favre J, Thuillez C, Richard V. NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection. Am. J. Physiol. Heart Circ. Physiol. 2003; 284: H2053-60.
12. Han J, Kim N, Joo H, Kim E, Earm YE. ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2002; 283: H1545-54.
13. Ockaili R, Salloum F, Hawkins J, Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am. J. Physiol. Heart Circ. Physiol. 2002; 283: H1263-9.
14. + channels and myocardial preconditioning. Circ. Res. 1999; 84: 973-9.
15. Reffelmann T, Kloner RA. Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation. Cardiovasc. Res. 2003; 59: 441-9.
16. Das A, Ockaili R, Salloum F, Kukreja RC. Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits. Am. J. Physiol. Heart Circ. Physiol. 2004; 286: H1455-60.
17. Salloum F, Yin C, Xi L, Kukreja RC. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ. Res. 2003; 92: 595-7.
18. Lisa FD, Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: Fixing a hole. Cardiovasc. Res. 2006; 70: 191-9.
19. Shannuganathan S, Hausenloy DJ, Duchen MR, Yellon DM. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am. J. Physiol. Heart Circ. Physiol. 2005; 289: H237-42.
20. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ. Res. 2003; 93: 292-301.
21. Suleiman MS, Halestrap AP, Griffiths EJ. Mitochondria: A target for myocardial protection. Pharmacol. Ther. 2001; 89: 29-46.
22. Costa ADT, Garlid KD, West IC et al. Protein kinase G transmits the cardioprotctive sigmal from cytosol to mitochondria. Circ. Res. 2005; 97: 329-36.
23. Cavalheiro RA, Marin RM, Rocco SA et al. Potent cardioprotective effect of the 4-anilinoquinazoline derivative PD153035: Involvement of mitochondrial K(ATP) channel activation. PLoS ONE 2010; 5: e10666.
24. Akao M, O'Rourke B, Kusuoka H, Teshima Y, Jones SP, Marbán E. Differential actions of cardioprotective agents on the mitochondrial death pathway. Circ. Res. 2003; 92: 195-202.
25. Kaasik A, Kuum M, Joubert F, Wilding J, Ventura-Clapier R, Veksler V. Mitochondria as a source of mechanical signals in cardiomyocytes. Cardiovasc. Res. 2010; 87: 83-91.
26. Lee GJ, Chae SJ, Jeong JH et al. Characterization of mitochondria isolated from normal and ischemic hearts in rats utilizing atomic force microscopy. Micron 2011; 42: 299-304.
27. Yan T, Sun R, Deng H, Tan B, Ao N. The morphological and biomechanical changes of keratocytes cultured on modified p (HEMA-MMA) hydrogel studied by AFM. Scanning 2009; 31: 246-52.
28. Lee GJ, Jeong JH, Lee SR et al. Quantitative and qualitative analysis of heart mitochondria for evaluating the degree of myocardial injury utilizing atomic force microscopy. Micron 2013; 44: 167-73.
29. Wu Y, Hu Y, Cai J et al. Time-dependent surface adhesive force and morphology of RBC measured by AFM. Micron 2009; 40: 359-64.
30. Gutsmann T, Fantner GE, Venturoni M et al. Evidence that collagen fibrils in tendons are inhomogeneously structured in a tubelike manner. Biophys. J. 2003; 84: 2593-8.
31. Strasser S, Zink A, Janko M et al. Structural investigations on native collagen type I fibrils using AFM. Biochem. Biophys. Res. Commun. 2007; 354: 27-32.
32. Choi YS, Ryu BK, Min HK, Lee SW, Pak YK. Analysis of proteome bound to d-loop region of mitochondrial DNA by DNA-linked affinity chromatography and reverse-phase liquid chromatography/tandem mass spectrometry. Ann. N.Y. Acad. Sci. 2005; 1042: 88-100.